$LAHO ..Regenerative Medicine RM) Industry..rapidly expanding in recent years, making it a high-value, fast-growth market..Big Pharma is also demonstrating a snowballing interest in regenerative medicine. The Regenerative Medicine (RM) Industry includes companies that are developing:
Stem cell therapies Cellular therapies Gene therapies Tissue engineering Direct cell reprogramming Exosome therapies Cellular scaffolds and matrices 3D bioprinting Biomaterials Combination Products And More
..Global Stem Cells Group (GSCG), a world leader in stem cell and regenerative medicine, announces it will represent CELLLINK 3D Bioprinting Technology in Latin America. CELLINK is the world’s first company biotech company to market bioinks for 3D bioprinting of human organs and tissue. http://www.stemcellsgroup.com/tag/3d-bioprinnting/
3D Bioprinting Market To Reach USD 4.40 Billion
.. rise in geriatric population, technological improvements for manufacturing customized Material Types, and growth in focus on R&D investment. Also, the increase in usage of 3D printing in cosmetic surgeries is anticipated to increase the market growth during the forecast period further.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.